MiR-181 inhibits the occurrence of sarcopenia mainly through 2 ways: (1) miR-181 increases the expression of MyoD and MyoG and promotes myogenic differentiation and expression of muscle markers [33, 34]; (2) It increase the proportion of type II muscle fibers in skeletal muscle, thereby increasing skeletal muscle strength [35]. This evidence concerns the gene MYOG and sarcopenia.